Medical Director Hematology, US OBU Medical Affairs

Takeda•Boston, MA

12d•$192,400 - $302,390

About The Position

The US Medical Director, CML & Ph+ ALL provides strategic medical and scientific leadership for Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) within US Medical Affairs. The role serves as the US medical subject-matter expert and is accountable for developing and driving the integrated US medical strategy in alignment with evolving science, clinical practice, patient needs, and global medical and development priorities.

Requirements

Advanced scientific or medical degree such as MD, DO, PhD, PharmD, or equivalent advanced degree in a relevant discipline.
Strong knowledge of hematologic malignancies.
Understanding of the evolving leukemia treatment landscape, clinical research, therapeutic modalities, and principles of evidence-based medicine.
Experience in Medical Affairs, Clinical Development, or a related scientific/clinical function within the pharmaceutical, biotechnology, academic, or healthcare environment.
Ability to critically evaluate and communicate complex clinical and scientific data to diverse internal and external audiences.
Experience developing or contributing to medical strategy, evidence generation, scientific communications, publications, and external scientific engagement.
Strong understanding of clinical trial design, data interpretation, and application of clinical evidence to Medical Affairs strategy.
Demonstrated ability to work effectively in a cross-functional and matrixed environment, including collaboration with global and U.S. partners.
Strong strategic thinking and ability to translate scientific insights into clear priorities and actionable medical initiatives.
Excellent written and verbal communication, presentation, collaboration, and stakeholder-management skills.
Ability to operate with scientific credibility, sound judgment, and a high degree of accountability and independence.
Understanding of applicable pharmaceutical industry compliance standards and the appropriate role of Medical Affairs.

Nice To Haves

Experience in leukemia or related hematologic cancers is strongly preferred.

Responsibilities

Develop and execute the U.S. Medical Affairs strategy and medical plan for leukemia, aligned with broader U.S. and global medical objectives.
Serve as a medical and scientific subject matter expert on leukemia, including disease biology, treatment landscape, emerging science, clinical data, and evolving standards of care.
Translate unmet medical needs and external stakeholder insights into medical priorities, evidence-generation plans, and scientific engagement strategies.
Provide medical leadership for pipeline and launch readiness, including scientific platform development, evidence-gap assessment, stakeholder engagement, and medical education.
Partner with Field Medical to shape scientific engagement priorities, identify actionable insights, and ensure insights are translated into Medical Affairs strategy and execution.
Engage appropriately with key external experts, investigators, cooperative groups, academic institutions, professional societies, and patient-focused organizations to advance scientific exchange and understand evolving needs within leukemia.
Support the development and execution of evidence-generation activities, including company-sponsored Medical Affairs studies, investigator-initiated research, collaborative studies, and real-world evidence initiatives, as appropriate.
Provide medical input into clinical development strategy and study execution, including assessment of unmet need, study concepts, patient populations, endpoints, and the evolving competitive landscape.
Lead or contribute to scientific communication and publication planning, including congress activities, manuscripts, abstracts, medical education, and other scientific materials.
Monitor and evaluate new clinical data, treatment guidelines, competitive developments, and changes in the leukemia treatment landscape and assess their implications for U.S. Medical Affairs strategy.
Collaborate with HEOR/RWE and Market Access partners to identify evidence needs relevant to patient care, treatment decision-making, and healthcare stakeholders.
Provide medical expertise to cross-functional teams while ensuring activities are conducted in accordance with applicable medical, legal, regulatory, compliance, and company standards.
Represent U.S. Medical Affairs on cross-functional and global teams, providing the U.S. medical perspective and ensuring alignment on key strategic priorities.
Develop strong internal and external scientific partnerships to advance the medical strategy and ultimately improve outcomes for patients with leukemia.